Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D.
Source: Life Science Leader
On this week's episode of the Business of Biotech, Edward (Ned) Patz, M.D., explains how a Duke University lab discovery turned into Grid Therapeutics and two clinical-stage cancer immunotherapy programs.
Access The Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene